ABSTRACT
Background There is evidence for an association of inflammation with cognitive functioning and dementia in older adults, but the association with cognitive functioning in youth and whether this is causal remains unclear.
Methods In a population-based cohort (Avon Longitudinal Study of Parents and Children; ALSPAC), we investigated cross-sectional associations of inflammatory markers (C-reactive protein [CRP] and Glycoprotein acetyls [GlycA]) with measures of cold (working memory, response inhibition) and hot (emotion recognition) cognition at age 24 (N=3,305 in multiple imputation models). Furthermore, we conducted one-sample and two-sample bidirectional Mendelian randomization (MR) analyses to examine potential causal effects of genetically-proxied inflammatory markers (CRP, GlycA, Interleukin-6, soluble Interleukin-6 receptor) on cognitive measures (above) and general cognitive ability.
Results In the ALSPAC cohort, there was limited evidence of an association between inflammatory markers and cognitive measures at age 24 after adjusting for potential confounders (N=3,305; beta range, -0.02 [95% confidence interval (CI) -0.06 to 0.02, p=.29] to 0.02 [95% CI -0.02 to 0.05, p=.38]). Similarly, primary MR analyses found limited evidence of potential effects of genetically-proxied inflammatory markers on working memory, emotion recognition or response inhibition in one-sample MR using ALSPAC data (beta range, -0.73 [95% CI -2.47 to 1.01, p=.41] to 0.21 [95% CI -1.42 to 1.84, p=.80]; or on general cognitive ability in two-sample MR using the latest Genome-Wide Association Study (GWAS) datasets (beta range, -0.02 [95% CI -0.05 to 0.01, p=.12] to 0.03 [95% CI -0.01 to 0.07, p=.19].
Conclusions Our findings do not provide strong evidence of a potential causal effect of inflammatory markers (CRP, Interleukin-6, GlycA) on the cognitive functions examined here. Given the large confidence intervals in the one-sample MR, larger GWAS of specific cognitive measures are needed to enable well-powered MR analyses to investigate whether inflammation causally influences hot/cold cognition.
Competing Interest Statement
The CHARGE Inflammation Working Group conducted GWAS of inflammation (CRP and IL-6) used in this study. MM is co-director of Jericoe Ltd, which produces software for the assessment and modification of emotion perception. The authors report no other biomedical financial interests or potential conflicts of interest.
Funding Statement
This work is supported by the Elizabeth Blackwell Institute for Health Research, University of Bristol, and the Wellcome Trust Institutional Strategic Support Fund (204813/Z/16/Z). This research was funded in whole, or in part, by the Wellcome Trust [Grant number 204813/Z/16/Z]. For the purpose of open access, the authors have applied a CC BY public copyright licence to any Author Accepted Manuscript version arising from this submission. This work was also supported by the Medical Research Council (MRC) Integrative Epidemiology Unit at the University of Bristol (MC_UU_00011/1, MC_UU_00011/3, MC_UU_00011/7). GMK acknowledges funding support from the Wellcome Trust (Grant No. 201486/Z/16/Z), and the UK Medical Research Council (Grant No. MC_PC_17213, Grant No. MR/S037675/1, and Grant No. MR/W014416/1). HJ is supported by the NIHR Biomedical Research Centre at University Hospitals Bristol and Weston NHS Foundation Trust and the University of Bristol. The views expressed are those of the authors and not necessarily those of the NIHR or the Department of Health and Social Care. GDS and KT work in the MRC Integrative Epidemiology Unit at the University of Bristol which is supported by the Medical Research Council (MC_UU_00011/1 and MC_UU_00011/3). CD is supported by an MRC Integrative Epidemiology Unit Fellowship (MC_UU_00011/1). The UK Medical Research Council and Wellcome (Grant ref: 217065/Z/19/Z) and the University of Bristol provide core support for ALSPAC. This publication is the work of the authors and CS will serve as guarantor for the contents of this paper. A comprehensive list of grants funding is available on the ALSPC website (grant-acknowledgements.pdf (bristol.ac.uk); This research was specifically funded by Wellcome Trust and MRC (Grant Ref: 076467/Z/05/Z; MR/L022206/1). GWAS data was generated by Sample Logistics and Genotyping Facilities at Wellcome Sanger Institute and LabCorp (Laboratory Corporation of America) using support from 23andMe.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Ethical approval for the study was obtained from the ALSPAC Ethics and Law Committee and the Local Research Ethics Committees (http://www.bristol.ac.uk/alspac/researchers/research-ethics/). Consent for biological samples has been collected in accordance with the Human Tissue Act (2004). Informed consent for the use of data collected via questionnaires and clinics was obtained from participants following the recommendations of the ALSPAC Ethics and Law Committee at the time. ALSPAC study data were collected and managed using REDCap electronic data capture tools hosted at the University of Bristol (Harris et al., 2009). REDCap (Research Electronic Data Capture) is a secure, web-based software platform designed to support data capture for research studies.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
↵* Joint senior authors
The Chan Zuckerberg Initiative, Cold Spring Harbor Laboratory, the Sergey Brin Family Foundation, California Institute of Technology, Centre National de la Recherche Scientifique, Fred Hutchinson Cancer Center, Imperial College London, Massachusetts Institute of Technology, Stanford University, University of Washington, and Vrije Universiteit Amsterdam.